Drug Product
Regulatory, Tech Transfer & Support Services
Company Overview
About
Danhson is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Bulgaria
Founded:1999
Employees:1,433
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval LMNNT3
Health Canada · #APR-0COKZO3O · 2019-05-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-NU3RF184
Issued: 2020-08-26
Expires: 2025-11-20
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-W5GK40AT
Issued: 2020-08-06
Expires: 2025-10-22
Health Canada GMP
Health Canada
Cert #: CERT-FYBJ5LO0
Issued: 2020-07-11
Expires: 2025-03-05
Loading CDMO intelligence...
Key facts about Danhson
- Danhson is headquartered in Bulgaria.
- Danhson was founded in 1999.
- Danhson has 1,433 employees.
- Danhson's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Danhson
Directory pages this company appears in, each with the full list of matching manufacturers.